2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$17.66+$0.11 (+0.63%)
Price as of Sep 11, 2026 7:58 PM EDT- $14.0BMarket Cap
- -7.34%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$17.66+$0.11 (+0.63%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.55 | ||
Change | +$0.55 (+3.24%) | ||
Open | $17.20 | ||
High | $17.70 | ||
Low | $17.14 | ||
Previous Close | $17.00 | ||
Volume | 4,278,037 | ||
30-Day Average Volume | 6,411,417 | ||
1-Week Change | -0.31% | ||
1-Month Change | 16.11% | ||
1-Year Change | -7.34% | ||
3-Year Change | 976.69% | ||
5-Year Change | 170.00% | ||
Fundamentals | |||
Shares Outstanding | 797.7M | ||
Total Assets | $752.2M | ||
Market Cap | $14.0B | ||
Enterprise Value | $13.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$215.7M | ||
Free Cash Flow | -$142.0M | ||
EBIT | -$215.7M | ||
EBITDA | -$215.7M | ||
Net Working Capital | $617.0M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -63 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 22 | ||
P/E | -63 | ||
PEG | 4 | ||
Price/Free Cash Flow | -99 | ||
Price/Operating Cash Flow | -99 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue